Biotest Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Michael Ramroth
Chief executive officer
€2.7m
Total compensation
| CEO salary percentage | 20.4% |
| CEO tenure | 19.3yrs |
| CEO ownership | n/a |
| Management average tenure | 1.4yrs |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -€47m |
| Dec 31 2022 | n/a | n/a | -€32m |
| Sep 30 2022 | n/a | n/a | -€69m |
| Jun 30 2022 | n/a | n/a | -€65m |
| Mar 31 2022 | n/a | n/a | -€54m |
| Dec 31 2021 | €3m | €555k | -€63m |
| Sep 30 2021 | n/a | n/a | -€28m |
| Jun 30 2021 | n/a | n/a | -€33m |
| Mar 31 2021 | n/a | n/a | -€35m |
| Dec 31 2020 | €2m | €462k | -€31m |
| Sep 30 2020 | n/a | n/a | -€34m |
| Jun 30 2020 | n/a | n/a | -€24m |
| Mar 31 2020 | n/a | n/a | -€15m |
| Dec 31 2019 | €1m | €426k | -€5m |
| Sep 30 2019 | n/a | n/a | -€9m |
| Jun 30 2019 | n/a | n/a | -€3m |
| Mar 31 2019 | n/a | n/a | -€6m |
| Dec 31 2018 | €1m | €355k | -€13m |
| Sep 30 2018 | n/a | n/a | €18m |
| Jun 30 2018 | n/a | n/a | €6m |
| Mar 31 2018 | n/a | n/a | €500k |
| Dec 31 2017 | €1m | €355k | -€16m |
| Sep 30 2017 | n/a | n/a | -€48m |
| Jun 30 2017 | n/a | n/a | -€47m |
| Mar 31 2017 | n/a | n/a | -€29m |
| Dec 31 2016 | €1m | €355k | €6m |
Compensation vs Market: Michael's total compensation ($USD2.97M) is above average for companies of similar size in the UK market ($USD1.95M).
Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.
CEO
Michael Ramroth (61 yo)
19.3yrs
Tenure
€2,724,000
Compensation
Dr. Michael Ramroth serves as Chairman of the Management Board and CEO at Biotest Aktiengesellschaft since May 01, 2019. Dr. Ramroth serves as Chief Financial Officer at Biotest Aktiengesellschaft. He serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Management Board & CEO | 19.3yrs | €2.72m | no data | |
| Member of Management Board & CFO | less than a year | no data | no data | |
| Chief Scientific Officer & Member of the Management Board | 1.4yrs | no data | no data | |
| COO & Member of Management Board | less than a year | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Head of Corporate HR | 7.8yrs | no data | no data | |
| Member of Supervisory Board | 1.4yrs | no data | no data |
1.4yrs
Average Tenure
50yo
Average Age
Experienced Management: BIO3D's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Supervisory Board | 1.1yrs | no data | no data | |
| Member of Supervisory Board | 1.1yrs | no data | no data | |
| Member of Supervisory Board | less than a year | no data | no data | |
| Chairman of the Supervisory Board | 1.1yrs | €598.00k | no data | |
| Member of Supervisory Board | less than a year | no data | no data | |
| Employee Representative Member of Supervisory Board | 11.8yrs | €44.00k | no data |
1.1yrs
Average Tenure
59yo
Average Age
Experienced Board: BIO3D's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.